Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Lower Extremity Arteriosclerosis Occlusive Lumen

This trial was a prospective, multicenter, single-group design. To undergo endovascular treatment of lower extremity arteriosclerosis obliterans After the subjects were selected and enrolled, the surgeons used the endovascular interventional surgical instrument control system developed by Shanghai Aopeng Medical Technology Co., Ltd. and the consumables of the endovascular interventional surgical instrument control system for the interventional hand Instrumentation (guide wire, catheter, stent, balloon) for remote delivery, manipulation, and withdrawal

Inclusion Criteria:Meet all the following criteria to be included in the group.Age: 18 years old or above, regardless of gender.Suffering from arteriosclerosis obliterans of lower limbs, it has the indication of endovascular treatment.Volunteer to participate in the test and sign the informed consent form.Exclusion Criteria:General criteria: If any of the following criteria is met, it cannot be included in the group.Pregnant or lactating women, or women of childbearing age with positive pregnancy test results.The target vessels were treated by arterial bypass grafting.Subjects participated in other clinical trials within 3 months before the screening period.Allergic history or contraindication of antiplatelet drugs, anticoagulants, anesthetics, contrast agents, scaffold materials and their coating drugs.Severe infection that is difficult to control.Vascular criteria: According to the CTA judgment of the diseased vessels, if any of the following criteria is met, they can not be included in the group.Perforation, dissection or aneurysm of the diseased vessel or the proximal vessel of the diseased vessel.The investigator believed that the vascular conditions were not suitable for the use of the test medical device.